We are live on ! Find out more
KAM

Krensavage Asset Management Portfolio holdings

AUM $256M
1-Year Est. Return 69.63%
This Fund
S&P 500
This Quarter Est. Return
-10.44%
1 Year Est. Return
+69.63%
3 Year Est. Return
+113.28%
5 Year Est. Return
+196.5%
10 Year Est. Return
+463.27%
AUM
$279M
AUM Growth
-$34.7M
Cap. Flow
+$5.34M
Cap. Flow %
1.92%
Top 10 Hldgs %
74.24%
Holding
22
New
–
Increased
12
Reduced
10
Closed
–

Top Buys

Rank Stock Value
1
IVC
Invacare Corporation
IVC
+$2.67M
2
SRGA
Surgalign Holdings, Inc. Common Stock
SRGA
+$1.3M
3
UTHR icon
United Therapeutics
UTHR
+$1.14M
4
OFIX icon
Orthofix Medical
OFIX
+$116K
5
ENTA icon
Enanta Pharmaceuticals
ENTA
+$114K

Top Sells

Rank Stock Value
1
BXLT
BAXALTA INC COM STK (DE)
BXLT
+$138K
2
AMGN icon
Amgen
AMGN
+$75.5K
3
AVNS
Avanos Medical
AVNS
+$70.9K
4
CNMD icon
CONMED
CNMD
+$60.9K
5
AGN
Allergan plc
AGN
+$35.5K

Sector Composition

Rank Sector Weight
1 Healthcare 72.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BXLT
1
DELISTED
BAXALTA INC COM STK (DE)
BXLT
$29.7M 10.65%
734,885
-3,480
-0.5% -$138K
OFIX icon
2
Orthofix Medical
OFIX
$477M
$26.7M 9.58%
643,145
+2,969
+0.5% +$116K
ENTA icon
3
Enanta Pharmaceuticals
ENTA
$366M
$25.9M 9.3%
882,529
+4,083
+0.5% +$114K
UTHR icon
4
United Therapeutics
UTHR
$25.8B
$24.9M 8.93%
223,445
+8,989
+4% +$1.14M
TEVA icon
5
Teva Pharmaceuticals
TEVA
$40.8B
$21.1M 7.57%
394,519
+1,822
+0.5% +$107K
IPXL
6
DELISTED
Impax Laboratories, Inc.
IPXL
$18.8M 6.75%
587,882
+2,712
+0.5% +$95.3K
AVNS
7
DELISTED
Avanos Medical
AVNS
$16.2M 5.8%
562,289
-2,663
-0.5% -$70.9K
AMGN icon
8
Amgen
AMGN
$208B
$16.1M 5.77%
107,255
-508
-0.5% -$75.5K
SRGA
9
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$13.8M 4.95%
114,903
+12,339
+12% +$1.3M
CNMD icon
10
CONMED
CNMD
$1.39B
$13.7M 4.93%
327,460
-1,551
-0.5% -$60.9K
MRK icon
11
Merck
MRK
$322B
$13.6M 4.86%
268,521
+1,235
+0.5% +$60.5K
IVC
12
DELISTED
Invacare Corporation
IVC
$8.05M 2.89%
611,485
+188,205
+44% +$2.67M
AGN
13
DELISTED
Allergan plc
AGN
$7.04M 2.53%
26,270
-124
-0.5% -$35.5K
SPPI
14
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$6.95M 2.49%
1,092,162
-5,173
-0.5% -$26.5K
ASRT
15
DELISTED
Assertio
ASRT
$6.23M 2.23%
7,450
-29
-0.4% -$26.9K
SCMP
16
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
$6.1M 2.19%
558,229
+2,577
+0.5% +$32.6K
VXRT
17
DELISTED
Vaxart
VXRT
$4.04M 1.45%
244,964
+6,306
+3% +$112K
DSCI
18
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
$2.81M 1.01%
906,046
+4,212
+0.5% +$14.1K
STRR
19
DELISTED
Star Equity Holdings
STRR
$2.38M 0.85%
9,575
-45
-0.5% -$11.3K
JNP
20
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
$1.9M 0.68%
286,967
-1,359
-0.5% -$10K
HRC
21
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$1.73M 0.62%
34,442
-163
-0.5% -$7.69K

Similar funds

CIA
Corigliano Investment Advisers Raleigh, North Carolina $256M AUM 54.89% 1-Year Est. Return
2
2Xideas Kusnacht, Switzerland $255M AUM 0.46% 1-Year Est. Return
CIM
Caldwell Investment Management Toronto, Ontario, Canada $255M AUM 36.87% 1-Year Est. Return
JFG
Juno Financial Group Richmond, Virginia $255M AUM
PIP
Palisades Investment Partners Santa Monica, California $255M AUM 50.52% 1-Year Est. Return
LRIC
Long Road Investment Counsel Kalamazoo, Michigan $255M AUM 12.85% 1-Year Est. Return
GAMC
Garner Asset Management Corp Plano, Texas $255M AUM 22.93% 1-Year Est. Return
TIA
Tiemann Investment Advisors Menlo Park, California $255M AUM 21.35% 1-Year Est. Return

Krensavage Asset Management's Q1 2016 Portfolio in Review

As of Q1 2016, Krensavage Asset Management held 22 positions worth $279M, down 11% from $313M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Trading was light in Q1 2016: portfolio turnover was 0%. Krensavage Asset Management opened no new positions and made no exits, leaving the 22-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 73% of assets, up from 73% a quarter earlier.

  • Krensavage Asset Management added most to Invacare Corporation in Q1 2016, an estimated $2.67M increase.
  • Krensavage Asset Management's biggest Q1 2016 reduction was BAXALTA INC COM STK (DE), cutting an estimated $138K.
  • Krensavage Asset Management's ten largest holdings make up 74% of its $279M portfolio in Q1 2016.
  • Krensavage Asset Management opened 0 new positions and closed 0 in Q1 2016.
  • Krensavage Asset Management's portfolio value fell 11% quarter-over-quarter to $279M.

Based on Krensavage Asset Management's 13F filing for Q1 2016, filed 13 May 2016.